Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF1) receptor antagonists

被引：42

作者：

Saito, Tetsuji ^{[1
]}

Obitsu, Tetsuo ^{[1
]}

Minamoto, Chiaki ^{[1
]}

Sugiura, Tsuneyuki ^{[1
]}

Matsumura, Naoya ^{[1
]}

Ueno, Sonoko ^{[1
]}

Kishi, Akihiro ^{[1
]}

Katsumata, Seishi ^{[1
]}

Nakai, Hisao ^{[1
]}

Toda, Masaaki ^{[1
]}

机构：

[1] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2011年 / 19卷 / 20期

关键词：

Corticotrophin-releasing factor 1 receptor; Antagonist; MAJOR DEPRESSION; HORMONE; DMP696; PHARMACOLOGY; POTENT;

D O I：

10.1016/j.bmc.2011.08.055

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

To identify structurally novel CRF1 receptor antagonists, a series of bicyclic core antagonists, pyrazolo [1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines, imidazo[1,2-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines were designed, synthesized and evaluated as CRF1 receptor antagonists. Compounds 2-27 showed binding affinity (IC50 = 4.2-418 nM) and antagonist activity (EC50 = 4.0-889 nM). Compound 5 was found to show oral efficacy in an Elevated Plus Maze test in rats. Further chemical modification of them led us to discovery of the tricyclic core antagonists pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidines. The discovery process of these compounds is presented, as is the study of the structure-activity relationship. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：5955 / 5966

页数：12

共 50 条

[1] PYRAZOLO[1,5-A]PYRIMIDINES
DORN, H
ZUBEK, A
JOURNAL FUR PRAKTISCHE CHEMIE, 1971, 313 (05): : 969 - &
[2] 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists
Saito, Tetsuji
Obitsu, Tetsuo
Kondo, Takashi
Matsui, Toshiaki
Nagao, Yuuki
Kusumi, Kensuke
Matsumura, Naoya
Ueno, Sonoko
Kishi, Akihiro
Katsumata, Seishi
Kagamiishi, Yoshifumi
Nakai, Hisao
Toda, Masaaki
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (18) : 5432 - 5445
[3] Unusual rearrangement of imidazo[1,5-a]imidazoles and imidazo[1,2-b]pyrazoles into imidazo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines
Gambouz, Khadija
Driowya, Mohsine
Loubidi, Mohammed
Tber, Zahira
Allouchi, Hassan
El Kazzouli, Said
Akssira, Mohamed
Guillaumet, Gerald
RSC ADVANCES, 2019, 9 (50) : 29051 - 29055
[4] SYNTHESIS OF NEW PYRAZOLO[1,5-a]PYRIMIDINES
Kryl'skii, D. V.
Chuvashlev, A. S.
Arzamastsev, A. P.
Slivkin, A. I.
PHARMACEUTICAL CHEMISTRY JOURNAL, 2009, 43 (06) : 294 - 296
[5] Halogenation of Pyrazolo[1,5-a]Pyrimidines with NXS
Sang, Tian
Li, Chuntian
Jia, Fan
He, Jing
Liu, Yan
Vaccaro, Luigi
Liu, Jichang
Liu, Ping
POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (09) : 8037 - 8047
[6] Synthesis of disazo pyrazolo[1,5-a]pyrimidines
Karci, Fikret
Demirçali, Aykut
DYES AND PIGMENTS, 2007, 74 (02) : 288 - 297
[7] SYNTHESIS OF SUBSTITUTED PYRAZOLO [1,5-A] PYRIMIDINES
DEEB, A
ELMOBAYED, M
ESSAWY, AA
ELHAMID, AA
ELHAMID, AA
REVUE ROUMAINE DE CHIMIE, 1993, 38 (03) : 303 - 309
[8] Synthesis of new pyrazolo[1,5-a]pyrimidines
D. V. Kryl’skii
A. S. Chuvashlev
A. P. Arzamastsev
A. I. Slivkin
Pharmaceutical Chemistry Journal, 2009, 43 : 294 - 296
[9] PREPARATION AND CHARACTERIZATION OF PYRAZOLO[1,5-A]PYRIMIDINES
MAQUESTIAU, A
TAGHRET, H
VANDENEYNDE, JJ
BULLETIN DES SOCIETES CHIMIQUES BELGES, 1992, 101 (02): : 131 - 136
[10] Orally active 3-(3-pyridyl)pyrazolo[1,5-a]pyrimidines as nonpeptide CRF1 receptor antagonists.
Chen, C
Wilcoxen, K
Bozigian, H
Chen, T
Cha, M
McCarthy, JR
Huang, CQ
Haddach, M
Zhu, YF
Murphy, B
De Souza, EB
Grigoriadis, DE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U38 - U38

← 1 2 3 4 5 →